Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,394,000 | 1,979,000 | 7,722,000 | 6,939,000 | 5,158,000 |
| Depreciation Amortization | 1,946,000 | 1,955,000 | 2,105,000 | 2,108,000 | 2,092,000 |
| Income taxes - deferred | -363,000 | -1,330,000 | 183,000 | -607,000 | -108,000 |
| Accounts receivable | -378,000 | -58,000 | -214,000 | -420,000 | 136,000 |
| Accounts payable and accrued liabilities | -143,000 | 424,000 | -44,000 | -12,000 | 228,000 |
| Other Working Capital | 622,000 | 7,910,000 | 1,000 | 1,115,000 | 1,346,000 |
| Other Operating Activity | 1,218,000 | 297,000 | 601,000 | 608,000 | 100,000 |
| Operating Cash Flow | $11,296,000 | $11,177,000 | $10,354,000 | $9,731,000 | $8,952,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,027,000 | -3,193,000 | -7,677,000 | -4,421,000 | -4,982,000 |
| PPE Investments | -738,000 | -664,000 | -738,000 | -320,000 | -715,000 |
| Net Acquisitions | 195,000 | -19,000 | N/A | -359,000 | -165,000 |
| Purchase Of Investment | -40,000 | N/A | N/A | N/A | 533,000 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -285,000 |
| Other Investing Activity | -105,000 | -148,000 | -243,000 | -447,000 | -423,000 |
| Investing Cash Flow | $14,339,000 | $-4,024,000 | $-8,658,000 | $-5,547,000 | $-5,752,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 4,476,000 | 7,318,000 | 3,465,000 | 4,476,000 |
| Debt Repayment | -1,121,000 | -4,405,000 | -3,725,000 | -2,400,000 | -5,605,000 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 186,000 |
| Common Stock Repurchased | -17,794,000 | -3,160,000 | -2,965,000 | -1,867,000 | -138,000 |
| Dividend Paid | -3,507,000 | -3,365,000 | -2,998,000 | -2,396,000 | -1,851,000 |
| Other Financing Activity | -68,000 | -140,000 | -229,000 | -573,000 | -342,000 |
| Financing Cash Flow | $-22,490,000 | $-6,594,000 | $-2,599,000 | $-3,771,000 | $-3,274,000 |
| Beginning Cash Position | 3,800,000 | 3,241,000 | 4,144,000 | 3,731,000 | 3,805,000 |
| End Cash Position | 6,945,000 | 3,800,000 | 3,241,000 | 4,144,000 | 3,731,000 |
| Net Cash Flow | $3,145,000 | $559,000 | $-903,000 | $413,000 | $-74,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,296,000 | 11,177,000 | 10,354,000 | 9,731,000 | 8,952,000 |
| Capital Expenditure | -738,000 | -664,000 | -738,000 | -594,000 | -718,000 |
| Free Cash Flow | 10,558,000 | 10,513,000 | 9,616,000 | 9,137,000 | 8,234,000 |